Yahoo · Sep 14, 2026
Is AtriCure (ATRC) Stock Outpacing Its Medical Peers This Year?
Here is how AtriCure (ATRC) and Aveanna Healthcare (AVAH) have performed compared to their sector so far this year.
NASDAQ · AVAH
Aveanna Healthcare Holdings Inc.
Healthcare · Medical - Care Facilities
$14.31
Up+$0.32 (+2.20%)
Updated Sep 16, 2026, 3:32 PM
SID Score
5.5/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.9B
- P/E ratio
- 25.2
- Dividend yield
- 0.00%
- 52-week range
- $5.93 – $14.70
- Volume
- 3.48M
- Avg. volume
- 1.39M
Price performance
AVAH price history
1M range · 20 trading sessions · Daily adjusted prices
AVAH closed at $14.31 after 20 trading sessions, up 12.94% for the selected period.
- Last close
- $14.31
- Period change
- +12.94%
- Period low
- $12.67
- Period high
- $14.38
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $14.34 | $14.45 | $14.052 | $14.31 | 3.48M |
| Sep 14, 2026 | $14.27 | $14.695 | $14.20 | $14.38 | 2.59M |
| Sep 11, 2026 | $13.98 | $14.541 | $13.88 | $14.08 | 2.37M |
| Sep 10, 2026 | $14.03 | $14.1574 | $13.68 | $13.86 | 3.92M |
| Sep 9, 2026 | $13.66 | $14.045 | $13.47 | $14.02 | 3.14M |
| Sep 8, 2026 | $13.43 | $13.95 | $13.38 | $13.66 | 5.45M |
| Sep 4, 2026 | $13.58 | $13.83 | $13.46 | $13.58 | 1.84M |
| Sep 3, 2026 | $13.22 | $13.64 | $13.02 | $13.64 | 2.29M |
| Sep 2, 2026 | $13.53 | $13.6099 | $13.055 | $13.20 | 1.88M |
| Sep 1, 2026 | $13.38 | $13.565 | $13.222 | $13.46 | 2.05M |
| Aug 31, 2026 | $13.41 | $13.56 | $12.97 | $13.42 | 4.04M |
| Aug 28, 2026 | $13.90 | $13.90 | $13.275 | $13.32 | 2.22M |
| Aug 27, 2026 | $13.62 | $14.00 | $13.52 | $13.82 | 3.72M |
| Aug 26, 2026 | $13.65 | $13.915 | $13.42 | $13.62 | 2.51M |
| Aug 25, 2026 | $13.625 | $13.84 | $13.40 | $13.59 | 2.9M |
| Aug 24, 2026 | $13.48 | $13.98 | $13.375 | $13.70 | 5.37M |
| Aug 21, 2026 | $12.775 | $13.605 | $12.39 | $13.16 | 8.42M |
| Aug 20, 2026 | $13.04 | $13.395 | $12.895 | $12.97 | 3.29M |
| Aug 19, 2026 | $12.92 | $13.16 | $12.69 | $13.16 | 2.48M |
| Aug 18, 2026 | $12.68 | $12.76 | $12.23 | $12.67 | 5.05M |
Latest AVAH news
The latest Smart Investors Daily articles mentioning AVAH.
Stock researchCompany · Overview
AVAH research
Overview
Company profile and research snapshot.
Company profile
Aveanna Healthcare Holdings Inc is a diversified home care platform that provides care to medically complex, high-cost patient populations. It directly addresses the pressing challenges facing the U.S. healthcare system by providing safe, high-quality care in the home. The firm provides its services through three segments: Private Duty Services (PDS); Home Health & Hospice (HHH); and Medical Solutions (MS). Private Duty Services include private duty nursing (PDN) and pediatric therapy services. Revenue is derived from pediatric healthcare services provided to patients including private duty nursing and therapy services, adult home health and hospice services (collectively patient revenue) and from the delivery of enteral nutrition and other products to patients.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $10.80
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 14, 2026 | JP Morgan | Neutral | — |
| Aug 28, 2026 | Barclays | Overweight | — |
| Aug 24, 2026 | RBC Capital | Outperform | — |
| Aug 24, 2026 | Truist Securities | Hold | — |
| Aug 14, 2026 | Raymond James | Strong Buy | — |
News briefing
Generated Sep 16, 2026, 3:06 PM
Why Is AVAH Up Today?
Aveanna Healthcare Holdings Inc. (AVAH) is posting modest gains of 1.40% as the home healthcare provider reaches fresh highs, driven partly by renewed analyst attention. JP Morgan's decision to maintain its neutral stance while raising the price target to $15 suggests growing confidence in the company's valuation, even if sentiment remains cautiously optimistic.
Bottom line: AVAH's modest gains reflect steady progress and renewed analyst optimism, with JP Morgan's raised price target validating the company's growth trajectory even under a neutral stance. Investors should monitor upcoming earnings reports and margin trends to determine if the stock can sustain its climb toward and beyond the $15 target, while remaining cautious about valuation at fresh highs.
Yahoo · Sep 14, 2026
Aveanna Healthcare Holdings Inc. (AVAH) Hits Fresh High: Is There Still Room to Run?
Aveanna (AVAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Benzinga · Sep 14, 2026
JP Morgan Maintains Neutral on Aveanna Healthcare Hldgs, Raises Price Target to $15
JP Morgan analyst Benjamin Rossi maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Neutral and raises the price target from $8 to $15.
Yahoo · Sep 11, 2026
Stock Market Leaders Often Shine, Helped By This Sign Of Liquidity Strength
Sometimes thinly traded or low-priced stocks can be institutional quality when it comes to their average daily dollar volume.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
